Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic hepatitis B in hepatocarcinogenesis.

N H Park1, I H Song, Y-H Chung

  • 1Division of Gastroenterology, Department of Internal Medicine, University of Ulsan, College of Medicine, Asan Medical Centre, Seoul, Korea.

Postgraduate Medical Journal
|August 8, 2006
PubMed
Summary

Hepatocellular carcinoma (HCC), a common cancer, is largely caused by the hepatitis B virus (HBV). Preventing HBV infection and treating chronic hepatitis B are crucial for controlling HCC globally.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interpretable QSAR modelling for immunotoxicity prediction using enhanced fingerprint and SHAP-based feature selection.

SAR and QSAR in environmental research·2025
Same author

The ASAS-OMERACT core domain set for axial spondyloarthritis.

Seminars in arthritis and rheumatism·2021
Same author

Retraction Note: VP2 capsid domain of the H-1 parvovirus determines susceptibility of human cancer cells to H-1 viral infection.

Cancer gene therapy·2021
Same author

Lactobacillus-fermented milk products attenuate bone loss in an experimental rat model of ovariectomy-induced post-menopausal primary osteoporosis.

Journal of applied microbiology·2020
Same author

<i>Porphyromonas gingivalis</i> Impairs Oral Epithelial Barrier through Targeting GRHL2.

Journal of dental research·2019
Same author

Human Papillomavirus 16 E6 Induces FoxM1B in Oral Keratinocytes through GRHL2.

Journal of dental research·2018

Area of Science:

  • Hepatology
  • Oncology
  • Virology

Background:

  • Hepatocellular carcinoma (HCC) is a globally prevalent cancer with significant geographical variation.
  • Hepatitis B virus (HBV) infection is responsible for approximately 80% of HCC cases worldwide.
  • HBV-associated HCC development involves liver cirrhosis and potentially direct oncogenic effects of the virus.

Purpose of the Study:

  • To highlight the significant global burden of HCC attributed to HBV.
  • To emphasize the need for HBV prevention and chronic hepatitis B treatment for HCC control.
  • To underscore the importance of ongoing research into hepatocarcinogenesis mechanisms.

Main Methods:

  • Review of epidemiological data on HCC prevalence and HBV association.
  • Analysis of established and potential mechanisms of HBV-induced liver cancer.

Related Experiment Videos

  • Discussion of current strategies and future directions for HCC prevention and treatment.

    • Main Results:

    • HBV is the primary driver of HCC globally, predominantly through cirrhosis.
    • Direct oncogenic roles of HBV in hepatocarcinogenesis are also recognized.
    • Effective HBV prevention and treatment are essential for reducing HCC incidence.

    Conclusions:

    • Global control of HBV-associated HCC requires robust strategies for preventing HBV infection and managing chronic hepatitis B.
    • Further research into the molecular mechanisms of hepatocarcinogenesis is vital for advancing our understanding and therapeutic approaches.
    • Addressing the impact of HBV is critical for reducing the global burden of liver cancer.